An article published by Unknown Focus has provided independent recognition of the ONTOX Project and its contributions to the evolution of chemical safety assessment. The feature underscores ONTOX’s role in advancing scientifically robust and ethically responsible alternatives to conventional animal-based testing.
The article characterizes ONTOX as a leading European research initiative dedicated to transforming toxicological evaluation through the integration of innovative methodologies. Central to this effort is the application of New Approach Methodologies (NAMs), which combine in vitro systems based on human-derived cells with in silico computational models. This integrated framework enables a more precise and human-relevant understanding of how chemical exposures may lead to adverse health outcomes.
Article by Unknown Focus capturing the ONTOX’s main vision.
Particular attention is given to ONTOX’s focus on critical biological systems, including the liver, kidney, and developing brain. These areas are of high relevance for regulatory toxicology, as they are frequently implicated in both acute and chronic toxicity. By concentrating on these systems, the project aims to improve the prediction of long-term effects and support more informed risk assessment.
The article further highlights the development of advanced “physiological maps,” which represent detailed, data-driven models of normal organ function. These maps provide a structured platform for integrating mechanistic toxicological data and exposure information, enabling the simulation of chemical interactions within the human body. Such approaches represent a significant step toward predictive, mechanism-based risk assessment.
In addition, the coverage emphasizes ONTOX’s alignment with European policy objectives aimed at reducing and ultimately replacing animal testing. By leveraging artificial intelligence and high-quality human-relevant data, the project contributes to the modernization of regulatory frameworks and supports the transition toward more sustainable and ethical scientific practices.
Moreover, the article reviews a selection of the more than 60 publications produced by ONTOX to date, highlighting several of the most notable contributions.
Finally, the article acknowledges ONTOX’s broader engagement with stakeholders across science, regulation, and industry, as well as its efforts to communicate complex scientific developments to wider audiences. This external perspective reinforces the growing recognition of ONTOX as a key contributor to next-generation risk assessment.
The independent coverage by Unknown Focus highlights the increasing visibility and impact of ONTOX, confirming its position at the forefront of efforts to deliver safer chemicals through innovative, non-animal approaches.